Multiple Myeloma: Possible Cure from the Sea.
bioactive compounds
cancer
marine natural product
marine organism
multiple myeloma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Jun 2022
16 Jun 2022
Historique:
received:
10
05
2022
revised:
03
06
2022
accepted:
12
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Multiple myeloma (MM) is a blood cancer that occurs in the plasma cells (PCs), a type of white blood cell. Despite the progress of several current treatments that prolong the overall patient's survival, most MM cases are incurable. For this reason, many efforts have been undertaken by the scientific community in the search for new treatments. BLENREP
Identifiants
pubmed: 35740630
pii: cancers14122965
doi: 10.3390/cancers14122965
pmc: PMC9220879
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : POR Campania FESR 2014-2020 "Technology Platform for Therapeutic Strategies against Can-cer"-Action 1.1.2 and 1.2.2
ID : Antitumor Drugs and Vaccines from the Sea (ADViSE)" project (CUP B43D18000240007-SURF 17061BP000000011; PG/2018/0494374)
Références
Br J Haematol. 2002 May;117(2):297-305
pubmed: 11972511
Ther Adv Hematol. 2014 Dec;5(6):197-210
pubmed: 25469210
J Nat Prod. 2014 Dec 26;77(12):2678-84
pubmed: 25490132
Nat Rev Dis Primers. 2017 Jul 20;3:17046
pubmed: 28726797
Lancet Oncol. 2021 Oct;22(10):1378-1390
pubmed: 34529931
Oncotarget. 2015 Apr 10;6(10):8200-9
pubmed: 25860931
Clin Biochem Rev. 2019 Feb;40(1):5-22
pubmed: 30828116
Br J Haematol. 2021 Dec;195(5):660-668
pubmed: 34036558
Mar Drugs. 2018 May 15;16(5):
pubmed: 29762545
Clin Cancer Res. 2016 Sep 15;22(18):4559-66
pubmed: 27117181
Drugs. 2020 Oct;80(15):1607-1613
pubmed: 32936437
Biomed Pharmacother. 2018 Sep;105:233-245
pubmed: 29859466
Mar Drugs. 2019 May 07;17(5):
pubmed: 31067655
Front Immunol. 2021 Feb 24;12:632937
pubmed: 33717171
Mol Cancer Res. 2018 Jul;16(7):1138-1148
pubmed: 29592898
Mar Drugs. 2019 Aug 23;17(9):
pubmed: 31443597
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109897
pubmed: 31500019
Blood. 2019 Oct 17;134(16):1337-1345
pubmed: 31484647
Blood. 2009 Apr 16;113(16):3781-91
pubmed: 19020308
Oncotarget. 2019 Apr 12;10(28):2709-2721
pubmed: 31105871
ACS Chem Biol. 2013;8(6):1241-52
pubmed: 23547759
N Engl J Med. 2021 Feb 25;384(8):705-716
pubmed: 33626253
J Nat Prod. 2007 Feb;70(2):269-76
pubmed: 17243724
Future Oncol. 2020 Jan;16(2):4347-4358
pubmed: 31833394
Am Soc Clin Oncol Educ Book. 2016;35:e418-23
pubmed: 27249749
Arch Pharm Res. 2017 May;40(5):592-600
pubmed: 28275987
Br J Haematol. 2016 Feb;172(4):625-8
pubmed: 26033438
Cancers (Basel). 2021 Oct 04;13(19):
pubmed: 34638462
Leukemia. 2019 Oct;33(10):2343-2357
pubmed: 31455853
Cancers (Basel). 2020 Jan 22;12(2):
pubmed: 31979059
Cancer Chemother Pharmacol. 2010 May;66(1):129-40
pubmed: 19779717
Lancet. 2019 Jul 6;394(10192):29-38
pubmed: 31171419
JBMR Plus. 2021 Jun 15;5(8):e10518
pubmed: 34368608
ACS Omega. 2017 Apr 30;2(4):1477-1488
pubmed: 30023636
Drugs Today (Barc). 2020 May;56(5):337-347
pubmed: 32406881
Ann Oncol. 2021 Jan;32(1):34-48
pubmed: 33098993
Br J Haematol. 2018 Jan;180(1):41-51
pubmed: 29076150
Mar Drugs. 2018 Oct 21;16(10):
pubmed: 30347865
Biochem Pharmacol. 2020 Feb;172:113744
pubmed: 31812675
Blood. 2011 May 26;117(21):5692-700
pubmed: 21454451
N Engl J Med. 2015 Sep 24;373(13):1207-19
pubmed: 26308596
Haematologica. 2017 Jan;102(1):168-175
pubmed: 27540138
Clin Cancer Res. 2013 Apr 15;19(8):2048-60
pubmed: 23344265
Cancer Cell. 2014 Jan 13;25(1):91-101
pubmed: 24434212
Mar Drugs. 2013 Nov 08;11(11):4451-63
pubmed: 24217287
Nature. 2011 Mar 24;471(7339):467-72
pubmed: 21430775
Nurs Clin North Am. 2017 Mar;52(1):65-81
pubmed: 28189167
Bone Marrow Transplant. 2008 Jan;41(1):51-4
pubmed: 17934529
N Engl J Med. 2017 Apr 6;376(14):1311-1320
pubmed: 28379796
Anticancer Res. 2013 Nov;33(11):4719-26
pubmed: 24222106
Blood. 2016 Jun 2;127(22):2693-700
pubmed: 27009059
J Oncol. 2019 Nov 3;2019:6084012
pubmed: 31781214
Biomedicines. 2022 Jan 28;10(2):
pubmed: 35203517
Blood. 2011 Jan 13;117(2):393-402
pubmed: 21030562
Mar Drugs. 2018 Aug 21;16(9):
pubmed: 30134565
N Engl J Med. 2019 May 2;380(18):1726-1737
pubmed: 31042825
N Engl J Med. 2019 Aug 22;381(8):727-738
pubmed: 31433920
Leukemia. 2018 Dec;32(12):2604-2616
pubmed: 29789651
Med J Aust. 2019 May;210(8):375-380
pubmed: 31012120
Mar Drugs. 2018 Jun 13;16(6):
pubmed: 29899231
Med J Aust. 2005 Oct 3;183(7):344
pubmed: 16201949
Onco Targets Ther. 2019 Mar 14;12:1965-1977
pubmed: 30936716
Cancer Res. 2008 Jul 1;68(13):5216-25
pubmed: 18593922
Mar Drugs. 2019 Dec 26;18(1):
pubmed: 31887976
N Engl J Med. 2016 Oct 6;375(14):1319-1331
pubmed: 27705267